Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 10.532
Filtrar
1.
Sao paulo; APH; abr. 2020. 46 p.
Monografia em Português | LILACS, HomeoIndex - Homeopatia | ID: biblio-1088074

RESUMO

A infecção humana causada pelo vírus SARS-CoV-2 (COVID-19), diagnosticada como pneumonia de causa desconhecida originalmente na cidade de Wuhan (China), foi considerada como pandemia pela Organização Mundial da Saúde. Sua transmissibilidade parece ser bastante elevada, tendo afetado quase dois milhões de pessoas em todo o mundo e provocado mais de 130 mil mortes. Surgiu no Brasil em fevereiro de 2020, inicialmente na cidade de São Paulo. Afeta de forma mais grave os idosos e portadores de algumas comorbidades (tais como doenças cardiovasculares, hipertensão arterial, diabetes, câncer, DPOC e doenças cerebrovasculares, entre outras), tendo uma sintomatologia variável e tratamentos empíricos que estão sendo testados de forma mais rigorosa desde o seu aparecimento. Na ausência de vacina para proteção dos sadios, tem sido adotada a estratégia de isolamento social e tratamento com medidas de suporte geral e/ou avançado. Neste contexto, cabe investigar a contribuição da terapêutica homeopática no enfrentamento da doença, notadamente no alívio dos sintomas desconfortáveis por ela provocados em sua fase inicial, com acompanhamento e registro dos resultados obtidos pelos médicos homeopatas. Este estudo nacional pretende coletar, durante o período em que durar a pandemia da COVID-19 no Brasil, informações de pacientes diagnosticados com a doença, tratados com medicamentos homeopáticos escolhidos de acordo com a sintomatologia apresentada pelo paciente, por experientes médicos homeopatas. Todos os medicamentos homeopáticos estão descritos na Farmacopéia Homeopática Brasileira, não envolvendo qualquer medicamento que não tenha sido anteriormente aprovado para uso homeopático. Serão avaliados os efeitos no estado de saúde do paciente, por meio de escores e escalas clínicas, bem como aspectos relacionados à segurança do medicamento, variação na duração da doença e medicamentos mais associados a eventuais sucessos terapêuticos. Questionário padronizado e específico para a COVID-19 foi elaborado e disponibilizado em formulários google para preenchimento dos médicos colaboradores do estudo durante o acompanhamento dos pacientes. Os dados serão armazenados em planilhas eletrônicas e serão analisados com técnicas estatísticas descritivas e inferenciais. Todos os dados dos pacientes serão coletados de forma totalmente anonimizada para proteger a privacidade dos pacientes, que serão identificados no formulário eletrônico, única e exclusivamente, por um código alfanumérico, escolhido pelo seu médico homeopata e registrado no seu prontuário médico. Dada a situação pandêmica, nos casos em que não for possível o atendimento presencial será enviado uma folha de informações sobre o estudo e TCLE para preenchimento pelo paciente, bem como feitas as teleconsultas de seguimento para acompanhamento do caso. Além de gerar o desenvolvimento de novas aplicações da telemedicina na área homeopática, o projeto visa também a coleta de informações úteis que poderão ser utilizadas em futuros estudos multicêntricos randomizados e controlados para tratamento com medicamentos homeopáticos de quadros epidêmicos, podendo servir também de modelo para novos estudos clínicos de avaliação dos benefícios do tratamento homeopático em outras doenças ou agravos à saúde. (AU)


Infection in humans caused by the SARS-CoV-2 virus (COVID-19), diagnosed as pneumonia of unknown cause originally in the city of Wuhan (China) in December 2019, was considered a pandemic by the World Health Organization. Its transmissibility seems to be quite high, affecting almost two million people worldwide and causing more than 130 thousand deaths. It appeared in Brazil in February 2020, initially in the city of São Paulo. It affects more severely the elderly and people with some comorbidities (such as cardiovascular diseases, high blood pressure, diabetes, malignancy, chronic obstructive pulmonary disease and cerebrovascular disease, among others), with a rich clinical symptomatology. Empirical treatments are being tested in more rigorous clinical trials. In the absence of a vaccine to protect the healthy, the strategy of social isolation and treatment with general and / or advanced support measures has been adopted. In this context, it is worth investigating the potential contribution of homeopathy for relieving the distressing symptoms caused by coronavirus in its initial phase, together with monitoring and recording outcomes collected by homeopathic doctors. This national study intends to collect information from suspected or confirmed cases of COVID-19 patients, during the current pandemic in Brazil. The patients will be attended by experienced homeopathic doctors with the prescription of remedies according to the symptoms presented by the patient in the pandemic. All homeopathic medicines are described in the Brazilian Homeopathic Pharmacopoeia. The effects on patients' health status will be evaluated by means of scores and clinical scales, together with measures on safety, duration of the disease and medicines better related with good results. A standardized and specific questionnaire for COVID-19 had been designed and will be available on google forms to be filled out by doctors during the study. The data will be stored in electronic spreadsheets and will be analyzed using descriptive and inferential statistical techniques. All patient data will be collected in a completely anonymous way to protect patients' privacy. Patients will be identified exclusively by an alphanumeric code, to be registered in doctors' medical records. Given the pandemic situation, in cases in which face-to-face health care is not obligatory, an information sheet about the study will be sent to the patient in order to get the informed consent. Teleconsultations will take place in some cases for follow-up of patients. In addition to enlarge telemedicine applications for homeopathy, this project also aims to collect useful information that could be used in future randomized and controlled multicenter trials to evaluate the role of homeopathy in epidemic or transmissible diseases. It could also be helpful for designing clinical studies using homeopathic medicines in other diseases or health problems. (AU)


La infección en humanos causada por el virus SARS-CoV-2 (COVID-19), diagnosticada como neumonía de causa desconocida originalmente en la ciudad de Wuhan (China) en diciembre de 2019, fue considerada una pandemia por la Organización Mundial de la Salud. Su transmisibilidad parece ser bastante alta, afectando a casi dos millones de personas en todo el mundo y causando más de 130 mil muertes. Apareció en Brasil en febrero de 2020, inicialmente en la ciudad de São Paulo. Afecta más severamente a los ancianos y personas con algunas comorbilidades (como enfermedades cardiovasculares, presión arterial alta, diabetes, malignidad, enfermedad pulmonar obstructiva crónica y enfermedad cerebrovascular, entre otros), con una rica sintomatología clínica. Los tratamientos empíricos se están probando en ensayos clínicos más rigurosos. En ausencia de una vacuna para proteger a los sanos, se ha adoptado la estrategia de aislamiento social y tratamiento con medidas de apoyo generales y / o avanzadas. En este contexto, se puede investigar la contribución potencial de la homeopatía para aliviar los síntomas causados por el coronavirus en su fase inicial, junto con el monitoreo y registro de los resultados recopilados por los médicos homeópatas. Este estudio nacional tiene la intención de recopilar información de casos sospechosos o confirmados de pacientes con COVID-19, durante la pandemia actual en Brasil. Los pacientes serán atendidos por médicos homeópatas experimentados con la prescripción de remedios de acuerdo con los síntomas presentados por el paciente en la pandemia. Todos los medicamentos homeopáticos se describen en la Farmacopea Homeopática Brasileña. Los efectos sobre el estado de salud de los pacientes se evaluarán mediante puntajes de síntomas y escalas clínicas, junto con medidas de seguridad, duración de la enfermedad y revelación de medicamentos más asociados con buenas respuestas clínicas. Se diseñó un cuestionario estandarizado y específico para COVID-19, que estará disponible en los formularios de Google para que los médicos lo completen durante el estudio. Los datos se almacenarán en hojas de cálculo electrónicas y se analizarán mediante técnicas estadísticas descriptivas e inferenciales. Todos los datos del paciente se recopilarán de forma completamente anónima para proteger la privacidad de los pacientes. Los pacientes serán identificados exclusivamente por un código alfanumérico, que se registrará en los registros médicos de los médicos. Dada la situación de pandemia, en los casos en que la atención médica presencial no es obligatoria, se enviará una hoja de información sobre el estudio al paciente para obtener el consentimiento informado. Se realizarán teleconsultas en algunos casos para el seguimiento de los pacientes. Además de ampliar las aplicaciones de telemedicina para la homeopatía, este protocolo también tiene como objetivo recopilar información útil que podría utilizarse en futuros ensayos multicéntricos controlados y aleatorizados para evaluar el papel de la homeopatía en enfermedades epidémicas o transmisibles. También podría ser útil para diseñar estudios clínicos con medicamentos homeopáticos en otras enfermedades o problemas de salud.(AU)


Assuntos
Humanos , Coleta de Dados , Avaliação de Resultados em Cuidados de Saúde , Infecções por Coronaviridae/terapia , Vírus da SARS , Homeopatia , Brasil/epidemiologia , Infecções por Coronavirus/epidemiologia
3.
Sâo Paulo; Marcus Zulian Teixeira; mar. 2020. 60 p.
Monografia em Inglês | HomeoIndex - Homeopatia, LILACS | ID: biblio-1088044

RESUMO

In addition to the recognized application in chronic diseases, individualized homeopathy can also act in a resolutive or complementary way in acute cases, including epidemic diseases. However, to achieve this intent, it presents a specific semiologic and therapeutic methodology that must be followed and respected, with the risk of not presenting the desired efficacy and safety. In the case of epidemic diseases, which due to the virulence of their agents causes a common symptomatological picture in most susceptible individuals, the individualized homeopathic medicine (homeopathic medicine of the epidemic genius) should present similarity with the set of characteristic symptoms and signs of the patients affected in the different stages of each epidemic outbreak. Studies show the efficacy and safety of this prophylactic and/or therapeutic practice in several epidemics of the past. Therefore, after the survey of possible homeopathic drugs individualized from the epidemic genius of each epidemic, its prophylactic and/or large-scale therapeutic application should be supported by previous clinical trials that demonstrate its efficacy and safety, in line with the ethical and bioethical aspects of research involving human beings. Fulfilling these premises of good clinical practice, we developed the current protocol with the objective of investigating, in a randomized, double-blind and placebo-controlled clinical trial, the effectiveness and safety of possible individualized homeopathic drugs of epidemic genius of COVID-19, in adjuvant and complementary treatment of patients affected by the disease. If effectiveness and safety are confirmed, and only in this condition, the medicine may be used in a generalized and collective manner in the treatment and prevention of the current epidemic. (AU)


Assuntos
Gênio Epidêmico , Protocolos Clínicos , Infecções por Coronavirus/prevenção & controle , Infecções por Coronavirus/terapia , Ética em Pesquisa , Vírus da SARS , Epidemias , Homeopatia , Brasil/epidemiologia
4.
São Paulo; AMHB;APH; mar. 2020. 62 p.
Monografia em Português | LILACS, HomeoIndex - Homeopatia, MOSAICO - Saúde integrativa | ID: biblio-1087238

RESUMO

Além da reconhecida aplicação nas doenças crônicas, a homeopatia individualizada também pode atuar de forma resolutiva ou complementar nos casos agudos, incluindo as doenças epidêmicas. No entanto, para atingir esse intento, apresenta uma metodologia semiológica e terapêutica específica que deve ser seguida e respeitada, com o risco de não apresentar a eficácia e a segurança desejada. No caso das doenças epidêmicas, que pela virulência dos seus agentes provoca um quadro sintomatológico comum na maioria dos indivíduos suscetíveis, o medicamento homeopático individualizado (medicamento homeopático do gênio epidêmico) deve apresentar semelhança com o conjunto de sinais e sintomas característicos dos pacientes acometidos nos diferentes estágios de cada surto epidêmico. Estudos evidenciam a eficácia e a segurança desta prática profilática e/ou terapêutica em diversas epidemias do passado. Assim sendo, após o levantamento dos possíveis medicamentos homeopáticos individualizados do gênio epidêmico de cada epidemia, sua aplicação profilática e/ou terapêutica em larga escala deve ser sustentada por ensaios clínicos prévios que demonstrem sua eficácia e segurança, em consonância com os aspectos éticos e bioéticos da pesquisa envolvendo seres humanos. Cumprindo essas premissas da boa prática clínica, elaboramos o atual protocolo com o objetivo de investigar, em ensaio clínico randomizado, duplo-cego e placebo-controlado, a eficácia e a segurança de possíveis medicamentos homeopáticos individualizados do gênio epidêmico da COVID-19, em tratamento adjuvante e complementar de pacientes acometidos pela doença. Caso a a eficácia e a segurança se confirme, e tão somente, o(s) medicamento(s) poderão ser utilizado de forma generalizada e coletiva no tratamento e na prevenção da atual epidemia. (AU)


In addition to the recognized application in chronic diseases, individualized homeopathy can also act in a resolutive or complementary way in acute cases, including epidemic diseases. However, to achieve this intent, it presents a specific semiological and therapeutic methodology that must be followed and respected, with the risk of not presenting the desired efficacy and safety. In the case of epidemic diseases, which due to the virulence of their agents causes a common symptomatological picture in most susceptible individuals, the individualized homeopathic medicine (homeopathic medicine of the epidemic genius) should present similarity with the set of characteristic symptoms and signs of the patients affected in the different stages of each epidemic outbreak. Studies show the efficacy and safety of this prophylactic and/or therapeutic practice in several epidemics of the past. Therefore, after the survey of possible homeopathic drugs individualized from the epidemic genius of each epidemic, its prophylactic and/or large-scale therapeutic application should be supported by previous clinical trials that demonstrate its efficacy and safety, in line with the ethical and bioethical aspects of research involving human beings. Fulfilling these premises of good clinical practice, we developed the current protocol with the objective of investigating, in a randomized, double-blind and placebo-controlled clinical trial, the efficacy and safety of possible individualized homeopathic drugs of epidemic genius of COVID-19, in adjuvant and complementary treatment of patients affected by the disease. If efficacy and safety are confirmed, and only in this condition, the medicine may be used in a generalized and collective manner in the treatment and prevention of the current epidemic. (AU)


Assuntos
Humanos , Gênio Epidêmico , Protocolos Clínicos , Coronavirus , Infecções por Coronaviridae/prevenção & controle , Infecções por Coronaviridae/terapia , Ética em Pesquisa , Vírus da SARS , Epidemias , Homeopatia , Brasil/epidemiologia
5.
São Paulo; AMHB; mar. 3, 2020. 21 p.
Monografia em Português | LILACS, HomeoIndex - Homeopatia, MOSAICO - Saúde integrativa | ID: biblio-1087382

RESUMO

Estamos no meio da pandemia do Covid-19, em franco desenvolvimento no Brasil. No momento há perspectivas terapêuticas medicamentosa sem fases iniciais de teste, especialmente para o tratamento dos casos graves, aqueles que implicam em internação ou encaminhamento para Unidades de Terapia Intensiva. Pouco tem sido abordado sobre tentativas de tratamento de pacientes com síndrome respiratória leve. Não há escolha terapêutica efetiva para o início do quadro e, desta forma, a doença cursa de acordo com a resposta imune ou suscetibilidade individual do acometido, e há muito pouco de efetivo e específico que altere a história natural dessa enfermidade. (AU)


Assuntos
Arsenicum Album/uso terapêutico , China officinalis/uso terapêutico , Chininum Arsenicosum/uso terapêutico , Gênio Epidêmico , Coronaviridae , Infecções por Coronaviridae , Bryonia , Pandemias , Homeopatia , Brasil/epidemiologia
6.
Rev. cuba. estomatol ; 56(4): e2207, oct.-dez. 2019. graf
Artigo em Português | LILACS | ID: biblio-1093260

RESUMO

RESUMO Introdução: A lesão central de células gigantes é própria dos ossos gnáticos, sendo um tumor benigno não odontogênico. É uma lesão de crescimento predominantemente lento, bem circunscrito e assintomático, geralmente diagnosticada através de algum exame de rotina ou, em casos mais avançados, quando se começa a visualizar alguma alteração estético-anatômica ou através da queixa do paciente de algum desconforto localizado na região. Objetivo: Ilustrar um caso clínico de lesão central de células gigantes e sua resolução envolvendo momento cirúrgico e reabordagem que inclui a homeopatia na proposta terapêutica. Apresentação do caso: Paciente do sexo feminino, inicialmente com 4 anos de idade com uma lesão na região de pré-maxila. Após avaliação radiográfica, tomográfica, exames sanguíneos e biópsia incisional, foi realizada, em primeiro momento, a exérese da lesão sob anestesia geral, por curetagem com aplicação de solução de carnoy. Após proservação e surgimento de imagem radiopaca nos exames, deu-se início ao tratamento não invasivo com homeopatia e injeções de corticoide visando à redução e neoformação óssea em área sugestiva de tecido cicatricial. Conclusões: Abordagens mais conservadoras podem ser, em muitos casos, uma opção plausível que acaba por livrar o paciente de cirurgias mutilantes(AU)


RESUMEN Introducción: La lesión central de células gigantes es propia de los huesos gnáticos, lo que constituye un tumor benigno no odontogénico. Es una lesión de crecimiento predominantemente lento, bien circunscrita y asintomática, generalmente diagnosticada a través de algún examen de rutina o en casos más avanzados cuando se empieza a visualizar alguna alteración estético-anatómica o el paciente que se queja de algún malestar localizado en la región. Objetivo: Presentar un caso clínico de lesión central de células gigantes y su resolución involucrando momento quirúrgico y reabordaje que incluye la homeopatía en la propuesta terapéutica. Presentación del caso: Paciente del sexo femenino, inicialmente con 4 años de edad con una lesión en la región de pre-maxila. Después de la evaluación radiográfica, tomográfica, exámenes sanguíneos y biópsia incisional con el diagnóstico, se realizó en un primer momento la exéresis de la lesión bajo anestesia general, por curetaje con aplicación de solución de carnoy. En los exámenes de acompañamiento, después de la aparición de imagen radiopaca, se inició el tratamiento no invasivo con homeopatía e inyecciones de corticoides para la reducción y neoformación ósea en el área sugestiva de tejido cicatricial. Conclusiones: Los enfoques más conservadores pueden ser, en muchos casos, una opción plausible que termina librando al paciente de cirugías de mutilación(AU)


ABSTRACT Introduction: Giant cell central lesion is characteristic of the gnathic bones, being a non-odontogenic benign tumor. Classified as a predominantly slow grotwh, well-circumscribed and asymptomatic lesion usually diagnosed through routine examination or in some and more advanced cases once it begins to create some aesthetic-anatomical alteration or when the patient starts complaining of some located discomfort in the region. Objective: To present a clinical case of central giant cell lesion and its resolution involving surgical approach and second management, which includes homeopathy as a therapeutic proposal. Case presentation: central giant cell lesion located in the premaxilla region in a 4 years old female patient. After radiographic, tomographic and blood exams evaluation, followed by incisional biopsy and diagnostic, leading to surgical approach to remove the entire lesion by curettage with Carnoy's solution application under general anesthesia. After appearance of radiopaque imaging in the proservation examinations, the non-invasive treatment by corticoid injection and homeopathy got started aiming the reduction of cicatricial tissue's suggestive area and neoformation of the bone. Conclusions : approaches that are more conservative can be, in many cases, a plausible option that ends up ridding the patient of mutilating surgeries(AU)


Assuntos
Humanos , Feminino , Pré-Escolar , Doenças Maxilares/cirurgia , Tumores de Células Gigantes/diagnóstico por imagem , Homeopatia/efeitos adversos
7.
Diagn. tratamento ; 24(4): [143-152], out - dez. 2019. tab
Artigo em Português | LILACS | ID: biblio-1049381

RESUMO

O texto busca esclarecer à classe médica as peculiaridades da homeopatia que, apesar de fazer parte do rol das especialidades médicas brasileiras desde 1980, não é ensinada na maioria das faculdades de medicina. Associada a essa lacuna na educação dos estudantes de medicina, que se reflete na desinformação e desconhecimento dos futuros médicos, a aplicação de pressupostos distintos dos propagados pela ciência hegemônica contribui para a disseminação de preconceitos arraigados na cultura médica, afastando graduandos e graduados do aprendizado de uma terapia bissecular que deveria fazer parte do arsenal terapêutico vigente. Empregando um princípio de cura que estimula o organismo a reagir contra seus próprios distúrbios e valorizando a individualidade enferma em seus múltiplos aspectos, o método homeopático de tratamento favorece a relação médico-paciente e estimula o raciocínio holístico na compreensão do complexo fenômeno do adoecimento humano, propiciando uma terapêutica de baixo custo, isenta de eventos adversos e que incrementa a resolutividade clínica das doenças crônicas em geral. Esta revisão narrativa da literatura foi desenvolvida com o intuito de correlacionar os pressupostos homeopáticos às evidências científicas que os fundamentam, realizando buscas eletrônicas nas bases de dados MEDLINE e LILACS por meio de termos que descrevem suas linhas de pesquisa.


Assuntos
Fundamentos da Homeopatia , Assistência Integral à Saúde , Medicina Baseada em Evidências , Educação Médica , Homeopatia
8.
J Law Med ; 27(1): 50-54, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31682341

RESUMO

In R (on the application of British Homeopathic Association) v National Health Service Commissioning Board [2018] EWHC 1359 (Admin) Supperstone J of the High Court of England and Wales delivered an internationally significant judgment on the processes required to be engaged in when guidance is given to medical practitioners about their involvement in homeopathic prescribing. This column explores the bases upon which the challenge by the British Homeopathic Association was lost and the repercussions of the judgment for the practice of non-evidence-based modalities, such as homeopathy.


Assuntos
Homeopatia , Legislação Médica , Inglaterra , Programas Nacionais de Saúde , País de Gales
9.
Prensa méd. argent ; 105(10): 686-692, oct 2019.
Artigo em Inglês | LILACS, BINACIS | ID: biblio-1025966

RESUMO

This paper explains the elementary law of homeopathy, the Law of Similars, on the bases of thermodynamic aspects by means of the chemical thermodynamic. Le Chatelier principle was used, to explain the re-establishment of starting biochemical equilibrium compartmentalized in individual human cells of an ill person consuming the remedy, to clarify the Law of Similars. In addition, the application of the Law of mass action during the re-establishment of the initial equilibrium in an ill person when digesting the remedy exposed the law of Similars as the strongest outcome of homeopathy


Assuntos
Humanos , Fenômenos Bioquímicos , Ação Farmacodinâmica do Medicamento Homeopático , Fundamentos da Homeopatia/história , Lei dos Semelhantes , Homeopatia/história
11.
Aten. prim. (Barc., Ed. impr.) ; 51(8): 499-505, oct. 2019. graf, tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-185753

RESUMO

Objetivo: Identificar el perfil sociodemográfico del usuario de la homeopatía en España. Diseño: Estudio cuantitativo. Emplazamiento: España. Corpus: Base de datos del Centro de Investigaciones Sociológicas (Estudio 3205, febrero de 2018), con un total de 2.486 entrevistas, y se analiza una submuestra (n = 124), que agrupa a todos los ciudadanos que afirman que han usado la homeopatía en España en los 12 meses anteriores. Mediciones principales: Se utilizaron los porcentajes, las medias y/o la desviación estándar de las medias, así como la significación de los cambios en las distintas variables analizadas entre la población en general y los usuarios específicos de la homeopatía en España. Esto se determinó mediante el análisis de la varianza o prueba χ2 de Pearson, dependiendo de la naturaleza de la variable en el estudio. Resultados: El perfil tipo del usuario de la homeopatía en España es una mujer, de clase media/alta, con estudios superiores universitarios y con una ideología política progresista. Conclusiones: El perfil trazado es similar al de otros estudios internacionales


Objective: To identify the sociodemographic profile of the homeopathy user in Spain. Design: Quantitative study. Location: Spain. Corpus: The Centre for Sociological Research database (Study 3205, February 2018), with a total of 2,486 interviews, and the sub-sample that includes all patients who have claimed to use homeopathy in Spain in the last 12 months (n = 124). Main measurements: The percentages, means and/or standard deviation of the factors were calculated, as well as the significance of the changes in the different variables analysed in the general population, and the specific users of homeopathy in Spain. This was determined by the variance analysis or Pearson's χ2 test, depending on the nature of the variable in the study. Results: The homeopathy user-type profile in Spain is a woman, of middle/high social status, with higher university studies, and with a progressive political ideology. Conclusions: The Spanish profile is similar to that in other international studies


Assuntos
Humanos , Homeopatia/tendências , Terapias Complementares , 24960 , Espanha , Inquéritos e Questionários , Meios de Comunicação , Rede Social
12.
Cochrane Database Syst Rev ; 9: CD009710, 2019 09 04.
Artigo em Inglês | MEDLINE | ID: mdl-31483486

RESUMO

BACKGROUND: Irritable bowel syndrome (IBS) is a common, chronic disorder that leads to decreased health-related quality of life and work productivity. A previous version of this review was not able to draw firm conclusions about the effectiveness of homeopathic treatment for IBS and recommended that further high quality RCTs were conducted to explore the clinical and cost effectiveness of homeopathic treatment for IBS. Two types of homeopathic treatment were evaluated in this systematic review: 1. Clinical homeopathy where a specific remedy is prescribed for a specific condition; 2. Individualised homeopathic treatment, where a homeopathic remedy based on a person's individual symptoms is prescribed after a detailed consultation. OBJECTIVES: To assess the effectiveness and safety of homeopathic treatment for IBS. SEARCH METHODS: For this update we searched MEDLINE, CENTRAL, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Allied and Complementary Medicine Database (AMED), the Cochrane IBD Group Specialised Register and trials registers from inception to 31 August 2018. SELECTION CRITERIA: Randomised controlled trials (RCTs), cohort and case-control studies that compared homeopathic treatment with placebo, other control treatments, or usual care, in adults with IBS were considered for inclusion. DATA COLLECTION AND ANALYSIS: Two authors independently assessed the risk of bias and extracted data. The primary outcome was global improvement in IBS as measured by an IBS symptom severity score. Secondary outcomes included quality of life, abdominal pain, stool frequency, stool consistency, and adverse events. The overall certainty of the evidence supporting the primary and secondary outcomes was assessed using the GRADE criteria. We used the Cochrane risk of bias tool to assess risk of bias. We calculated the mean difference (MD) and 95% confidence interval (CI) for continuous outcomes and the risk ratio (RR) and 95% CI for dichotomous outcomes. MAIN RESULTS: Four RCTs (307 participants) were included. Two studies compared clinical homeopathy (homeopathic remedy, asafoetida or asafoetida plus nux vomica) to placebo for IBS with constipation (IBS-C). One study compared individualised homeopathic treatment (consultation plus remedy) to usual care for the treatment of IBS in female patients. One study was a three armed RCT comparing individualised homeopathic treatment to supportive listening or usual care. The risk of bias in three studies (the two studies assessing clinical homeopathy and the study comparing individualised homeopathic treatment to usual care) was unclear on most criteria and high for selective reporting in one of the clinical homeopathy studies. The three armed study comparing individualised homeopathic treatment to usual care and supportive listening was at low risk of bias in four of the domains and high risk of bias in two (performance bias and detection bias).A meta-analysis of the studies assessing clinical homeopathy, (171 participants with IBS-C) was conducted. At short-term follow-up of two weeks, global improvement in symptoms was experienced by 73% (46/63) of asafoetida participants compared to 45% (30/66) of placebo participants (RR 1.61, 95% CI 1.18 to 2.18; 2 studies, very low certainty evidence). In the other clinical homeopathy study at two weeks, 68% (13/19) of those in the asafoetida plus nux vomica arm and 52% (12/23) of those in the placebo arm experienced a global improvement in symptoms (RR 1.31, 95% CI 0.80 to 2.15; very low certainty evidence). In the study comparing individualised homeopathic treatment to usual care (N = 20), the mean global improvement score (feeling unwell) at 12 weeks was 1.44 + 4.55 (n = 9) in the individualised homeopathic treatment arm compared to 1.41 + 1.97 (n=11) in the usual care arm (MD 0.03; 95% CI -3.16 to 3.22; very low certainty evidence).In the study comparing individualised homeopathic treatment to usual care, the mean IBS symptom severity score at 6 months was 210.44 + 112.4 (n = 16) in the individualised homeopathic treatment arm compared to 237.3 + 110.22 (n = 60) in the usual care arm (MD -26.86, 95% CI -88.59 to 34.87; low certainty evidence). The mean quality of life score (EQ-5D) at 6 months in homeopathy participants was 69.07 (SD 17.35) compared to 63.41 (SD 23.31) in usual care participants (MD 5.66, 95% CI -4.69 to 16.01; low certainty evidence).For In the study comparing individualised homeopathic treatment to supportive listening, the mean IBS symptom severity score at 6 months was 210.44 + 112.4 (n = 16) in the individualised homeopathic treatment arm compared to 262 + 120.72 (n = 18) in the supportive listening arm (MD -51.56, 95% CI -129.94 to 26.82; very low certainty evidence). The mean quality of life score at 6 months in homeopathy participants was 69.07 (SD 17.35) compared to 63.09 (SD 24.38) in supportive listening participants (MD 5.98, 95% CI -8.13 to 20.09; very low certainty evidence).None of the included studies reported on abdominal pain, stool frequency, stool consistency, or adverse events. AUTHORS' CONCLUSIONS: The results for the outcomes assessed in this review are uncertain. Thus no firm conclusions regarding the effectiveness and safety of homeopathy for the treatment of IBS can be drawn. Further high quality, adequately powered RCTs are required to assess the efficacy and safety of clinical and individualised homeopathy for IBS compared to placebo or usual care.


Assuntos
Homeopatia/métodos , Síndrome do Intestino Irritável/terapia , Fitoterapia/métodos , Constipação Intestinal/etiologia , Constipação Intestinal/terapia , Fibras na Dieta/uso terapêutico , Feminino , Humanos , Masculino , Qualidade de Vida , Ensaios Clínicos Controlados Aleatórios como Assunto
13.
Recurso na Internet em Espanhol | LIS - Localizador de Informação em Saúde | ID: lis-LISBR1.1-46739

RESUMO

Hablando de Homeopatía nace como UNA RESPUESTA A LA DEMANDA CRECIENTE DE INFORMACIÓN FIABLE, VERAZ Y RIGUROSA SOBRE LA HOMEOPATÍA por parte de profesionales y pacientes.


Assuntos
Homeopatia , Terapêutica Homeopática , Clínica Homeopática
14.
Complement Ther Clin Pract ; 37: 1-5, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31445361

RESUMO

The aim of the current study was to investigate the prevalence of the use the integrative and complementary practices (ICP) and its associated factors in Brazil. Data was obtained from the cross-sectional National Health Survey 2013 (NHS), which had 145,580 adults aged 18 or over were interviewed. The outcome was the use of any ICP over the last 12 months and independent variables were macro-region, sex, age, educational attainment, skin color/race, and chronic disease. The results show that the prevalence of ICPs use in Brazil was 4.1%, while the most used types were medicinal plants and phytotherapy (2.5%), acupuncture (0.9%) and homeopathy (0.6%). The prevalence of ICPs use was higher in the North Region, among older people, women, participants with higher educational attainment, and with a higher number of chronic diseases. The findings from the current study provide valuable evidence that can inform future evidence-based public policies in Brazil.


Assuntos
Terapia por Acupuntura/estatística & dados numéricos , Terapias Complementares/estatística & dados numéricos , Homeopatia/estatística & dados numéricos , Fitoterapia/estatística & dados numéricos , Adolescente , Adulto , Brasil , Doença Crônica , Estudos Transversais , Feminino , Inquéritos Epidemiológicos , Humanos , Masculino , Pessoa de Meia-Idade , Plantas Medicinais/química , Prevalência
15.
Recurso na Internet em Espanhol | LIS - Localizador de Informação em Saúde | ID: lis-LISBR1.1-46651

RESUMO

La Asamblea Nacional de Homeopatía (ANH) es la entidad que agrupa y representa a las sociedades médicas, veterinarias y farmacéuticas de nuestro país ante otras asociaciones nacionales e internacionales, instituciones y poderes públicos. informacion@homeopatiasuma.com


Assuntos
Homeopatia
17.
Acta Vet Scand ; 61(1): 30, 2019 Jul 12.
Artigo em Inglês | MEDLINE | ID: mdl-31300066

RESUMO

BACKGROUND: Veterinary remedies are intended to support animals in their recovery from diseases. Treatment outcome depends not only on the general effectiveness of the remedies themselves, but also on other prerequisites. This is true for antibiotics, but even more so for treatments with homeopathic products which are characterised by their individualised approach. While the effectiveness of homeopathy has been addressed in various clinical control trials, the practical conditions under which homeopathic products are used on dairy farms have not yet been investigated. This study provides an initial insight into the existing prerequisites on dairy farms for the use of homeopathy (i.e. the consideration of homeopathic principles) and on homeopathic treatment procedures (including anamnesis, clinical examination, diagnosis, selection of a remedy, follow-up checks, and documentation) on 64 dairy farms in France, Germany and Spain. The use of homeopathy was assessed via a standardised questionnaire during face-to-face interviews. RESULTS: The study revealed that homeopathic treatment procedures were applied very heterogeneously and differed considerably between farms and countries. Farmers also use human products without veterinary prescription as well as other prohibited substances. CONCLUSIONS: The subjective treatment approach using the farmers' own criteria, together with their neglecting to check the outcome of the treatment and the lack of appropriate documentation is presumed to substantially reduce the potential for a successful recovery of the animals from diseases. There is, thus, a need to verify the effectiveness of homeopathic treatments in farm practices based on a lege artis treatment procedure and homeopathic principles which can be achieved by the regular monitoring of treatment outcomes and the prevailing rate of the disease at herd level. Furthermore, there is a potential risk to food safety due to the use of non-veterinary drugs without veterinary prescription and the use of other prohibited substances.


Assuntos
Doenças dos Bovinos/terapia , Indústria de Laticínios/estatística & dados numéricos , Homeopatia/veterinária , Animais , Bovinos , Feminino , França , Alemanha , Homeopatia/estatística & dados numéricos , Espanha , Inquéritos e Questionários
18.
J Altern Complement Med ; 25(9): 890-901, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31290681

RESUMO

Objectives: In Part 1 of the review of physicochemical research performed on homeopathic preparations the authors identified relevant publications of sufficient reporting quality for further in-depth analysis. In this article, the authors analyze these publications to identify any empirical evidence for specific physicochemical properties of homeopathic preparations and to identify most promising experimental techniques for future studies. Methods: After an update of the literature search up to 2018, the authors analyzed all publications in terms of individual experiments. They extracted information regarding methodological criteria such as blinding, randomization, statistics, controls, sample preparation, and replications, as well as regarding experimental design and measurement methods applied. Scores were developed to identify experimental techniques with most reliable outcomes. Results: The publications analyzed described 203 experiments. Less than 25% used blinding and/or randomization, and about one third used adequate controls to identify specific effects of homeopathic preparations. The most promising techniques used so far are nuclear magnetic resonance (NMR) relaxation, optical spectroscopy, and electrical impedance measurements. In these three areas, several sets of replicated high-quality experiments provide evidence for specific physicochemical properties of homeopathic preparations. Conclusions: The authors uncovered a number of promising experimental techniques that warrant replication to assess the reported physicochemical properties of homeopathic preparations compared with controls. They further discuss a range of experimental aspects that highlight the many factors that need to be taken into consideration when performing basic research into homeopathic potentization. For future experiments, the authors generally recommend using succussed (vigorously shaken) controls, or comparing different homeopathic preparations with each other to reliably identify any specific physicochemical properties.


Assuntos
Materia Medica , Bibliometria , Homeopatia , Materia Medica/análise , Materia Medica/química , Materia Medica/classificação
19.
Complement Ther Med ; 45: 1-6, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31331544

RESUMO

OBJECTIVES: To assess earlier experiences and likelihood for use of methods used for the treatment of primary dysmenorrhoea, a very common problem in women. DESIGN: A consecutive group of patients (n = 205) visiting a private gynaecological practice in Weilburg, Germany, received an assessment form on which they were asked to provide earlier experiences with various methods for the treatment of primary dysmenorrhoea. They were also asked to rate the likelihood for use of various methods from conventional medicine as well as from complementary and alternative medicine. Half of them received information on efficacy, safety and costs based on the American Cancer Society Working Group grading system. RESULTS: Only 5.5% reported no experience with contraceptives or pain relievers and 26.7% had no experience with complementary and alternative medicine. The remaining patients had experience with a median of two (mean = 3.7, SD = 4.8) methods. Diet and homeopathy were the most frequently used methods from complementary and alternative medicine. In spite of the provision of information on efficacy, safety and costs, patients chose the methods based on earlier experience. Patients familiar with complementary and alternative medicine also did not see which areas belong together, e.g. homeopathy, Schüssler's salts and anthroposophy. CONCLUSIONS: In spite of the provision of information, patients preferred to use those methods they were already acquainted with. In order to allow patients to make better decisions, different ways should be gone in order to help patients make better decisions.


Assuntos
Dismenorreia/tratamento farmacológico , Dismenorreia/terapia , Adolescente , Adulto , Idoso , Feminino , Alemanha , Homeopatia/métodos , Humanos , Pessoa de Meia-Idade , Adulto Jovem
20.
Complement Ther Med ; 45: 136-141, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31331550

RESUMO

OBJECTIVES: Infantile colic is a common benign disease occurring in early infancy that may have a great impact on family life. In the present study, the effectiveness and safety of the complex homeopathic medicine Enterokind was compared with Simethicone for treating infantile colic. DESIGN AND SETTING: Current data were drawn from a prospective, multicenter, randomized, open-label, controlled clinical trial that was conducted in 2009 in 3 Russian outpatient clinics. Children received either Enterokind (Chamomilla D6, Cina D6, Colocynthis D6, Lac defloratum D6 and Magnesium chloratum D6) or Simethicone. Data from infants ≤ 6 months with infantile colic are presented here. MAIN OUTCOME MEASURES: The main outcomes assessments were the change of total complaints score (maximum 17 points) and total objective symptoms score (maximum 22 points) after 10 days of treatment. RESULTS: Data from 125 infants ≤ 6 months with infantile colic were analyzed. The differences in total complaints and objective symptoms scores between baseline and day 10, estimated from the ANCOVA model, were found to be highly significant (p < 0.0001; ITT) in favor of Enterokind, both for complaints (Δ=-2.38; 95% confidence interval (CI): [-2.87; -1.89]) and for objective symptoms (Δ=-2.07; 95% CI: [-2.65; -1.49]). 1 adverse event (AE), vomiting, occurred under Enterokind and was rated to be unlikely related to it; 4 AEs occurred under Simethicone. All AEs were non-serious. CONCLUSIONS: The current study indicates that Enterokind is an effective and safe homeopathic treatment for functional intestinal colic in infants ≤ 6 months.


Assuntos
Cólica/tratamento farmacológico , Criança , Pré-Escolar , Ensaios Clínicos como Assunto , Homeopatia/métodos , Humanos , Lactente , Recém-Nascido , Estudos Prospectivos , Simeticone/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA